Individualized Obesity Pharmacotherapy

NCT03374956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

193

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Phentermine-Topiramate
DRUG: Liraglutide
DRUG: Naltrexone/bupropion
DRUG: Phentermine

Sponsor

Mayo Clinic